| Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic J Matta, E Wiernik, O Robineau, F Carrat, M Touvier, G Severi, ... JAMA internal medicine 182 (1), 19-25, 2022 | 231 | 2022 |
| Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study F Carrat, X de Lamballerie, D Rahib, H Blanche, N Lapidus, F Artaud, ... MedRxiv, 2020.09. 16.20195693, 2020 | 78 | 2020 |
| Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort … F Carrat, X De Lamballerie, D Rahib, H Blanché, N Lapidus, F Artaud, ... International Journal of Epidemiology 50 (5), 1458-1472, 2021 | 70 | 2021 |
| Tracking Rift Valley fever: from Mali to Europe and other countries, 2016 C Tong, E Javelle, G Grard, A Dia, C Lacrosse, T Fourié, P Gravier, ... Eurosurveillance 24 (8), 1800213, 2019 | 41 | 2019 |
| Long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution O Robineau, M Zins, M Touvier, E Wiernik, C Lemogne, X de Lamballerie, ... JAMA Network Open 5 (11), e2240985-e2240985, 2022 | 39 | 2022 |
| Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV J Warszawski, L Meyer, JE Franck, D Rahib, N Lydié, A Gosselin, ... Plos one 17 (5), e0267725, 2022 | 20 | 2022 |
| A simple reverse genetics method to generate recombinant coronaviruses J Mélade, G Piorkowski, F Touret, T Fourié, JS Driouich, M Cochin, ... EMBO reports 23 (5), e53820, 2022 | 19 | 2022 |
| Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders T Robert, G Lano, M Giot, T Fourié, X de Lamballeri, O Jehel, ... Nephrology Dialysis Transplantation 37 (2), 390-392, 2022 | 19 | 2022 |
| Variability of Zika Virus incubation period in humans T Fourié, G Grard, I Leparc-Goffart, S Briolant, A Fontaine Open forum infectious diseases 5 (11), ofy261, 2018 | 19 | 2018 |
| Emergence of dengue virus serotype 2 in Mauritania and molecular characterization of its circulation in West Africa T Fourié, A El Bara, A Dubot-Pérès, G Grard, S Briolant, LK Basco, ... PLoS Neglected Tropical Diseases 15 (10), e0009829, 2021 | 17 | 2021 |
| Dengue virus type 1 infection in traveler returning from Benin to France, 2019 T Fourié, L Luciani, S Amrane, C Zandotti, I Leparc-Goffart, L Ninove, ... Emerging Infectious Diseases 26 (8), 1946, 2020 | 15 | 2020 |
| Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients M Giot, T Fourié, G Lano, PMS Villarroel, X Lamballeri, M Gully, L Samson, ... Clinical Kidney Journal 14 (10), 2239-2245, 2021 | 13 | 2021 |
| Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population F Carrat, PMS Villarroel, N Lapidus, T Fourié, H Blanché, C Dorival, ... Scientific Reports 12 (1), 1-10, 2022 | 10 | 2022 |
| Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy A Rico, L Ninove, A Maarouf, C Boutiere, P Durozard, S Demortiere, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (4 …, 2021 | 9 | 2021 |
| Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort … F Carrat, de lamballerie, Xavier, D Rahib, H Blanche, N Lapidus, F Artaud, ... INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 50 (5), 1755-1755, 2021 | 9* | 2021 |
| Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination … D Decarreaux, M Pouquet, C Souty, AM Vilcu, P Prévot-Monsacre, ... Viruses 14 (5), 957, 2022 | 7 | 2022 |
| Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer AL Couderc, L Ninove, E Nouguerède, D Rey, M Rebroin, A Daumas, ... Journal of geriatric oncology 13 (6), 850-855, 2022 | 6 | 2022 |
| Emergence of Indian lineage of ECSA chikungunya virus in Djibouti, 2019 T Fourié, A Dia, Q Savreux, VP de Santi, X de Lamballerie, ... International Journal of Infectious Diseases 108, 198-201, 2021 | 6 | 2021 |
| Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People L Capai, S Masse, T Fourié, D Decarreaux, J Canarelli, MH Simeoni, ... Frontiers in public health, 1078, 2021 | 4 | 2021 |
| Molecular characterization of Dengue virus serotype 1 infections in French travelers from Africa between 2013 and 2019 T Fourié, GA Durand, F Touret, G Piorkowski, A Dubot-Pérès, ... Frontiers in Virology 3, 18, 2023 | 3 | 2023 |
